product/service
-
-
Jun 14, 2024 product/service
-
-
product/service
-
Notice Regarding Launch of 3 Ingredients / 8 Products of Generic Drugs for KYOSOMIRAI PHARMA(162 KB)
-
-
Jun 14, 2024 product/service
-
-
product/service
-
Notice Regarding Change of Trade Names for 2 Ingredients and 3 Products Manufactured and Sold by the Company(103 KB)
-
-
Nov 01, 2023 product/service
-
-
product/service
-
Notice Regarding Approval of Partial Amendments to Dosage and Administration of Famciclovir Tablets 250mg “KYOSOMIRAI” and Famciclovir Tablets 250mg “KMP” for KYOSOMIRAI PHARMA(104 KB)
-
-
Jul 19, 2023 product/service
-
-
product/service
-
Notice Regarding Approval of Partial Amendments to Indications, Dosage and Administration of ROSUVASTATIN TABLETS 2.5mg/5mg “KYOSOMIRAI”, ROSUVASTATIN OD TABLETS 2.5mg/5mg “KYOSOMIRAI”, ROSUVASTATIN TABLETS 2.5mg/5mg “KMP”, ROSUVASTATIN OD TABLETS 2.5mg/5mg “KMP” for KYOSOMIRAI PHARMA(117 KB)
-
-
Jun 16, 2023 product/service
-
-
product/service
-
Notice Regarding Launch of 1 Ingredient / 3 Products of Generic Drugs for KYOSOMIRAI PHARMA(111 KB)
-
-
Jun 16, 2023 product/service
-
-
product/service
-
Notice Regarding Change of Trade Names for 5 Ingredients and 11 Products Manufactured and Sold by the Company(110 KB)
-
-
May 17, 2023 product/service
-
-
product/service
-
Notice Regarding Approval of Partial Amendments to Dosage and Administration of Donepezil Hydrochloride Tablets 3mg / 5mg / 10mg “FFP” and Donepezil Hydrochloride OD Tablets 3mg / 5mg / 10mg “FFP” for KYOSOMIRAI PHARMA(160 KB)
-
-
Dec 09, 2022 product/service
-
-
product/service
-
Notice Regarding Launch of 1 Ingredient / 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(125 KB)
-
-
Sep 08, 2022 product/service
-
-
product/service
-
TOHO PHARMACEUTICAL and Sysmex to Commence Dry Ice-free Supply of Quality Control Reagents for Clinical Chemistry Tests – Realizing a Sustainable Cold Chain –(340 KB)
-
-
Aug 15, 2022 product/service
-
-
product/service
-
Notice Regarding Marketing Approvals for 1 Ingredient / 2 Product of Generic Drugs for KYOSOMIRAI PHARMA(173 KB)
-
-
Jul 06, 2022 product/service
-
-
product/service
-
To Deliver Specialty Pharmaceuticals Safely and Securely
Notice Regarding a New Constant-Temperature Transportation Device “SALM FZ” which Provides a Rigorous Temperature Control in a Wide Range of Temperature(121 KB)
-
-
Jun 17, 2022 product/service
-
-
product/service
-
Notice Regarding Launch of 2 Ingredients / 3 Products of Generic Drugs for KYOSOMIRAI PHARMA(122 KB)
-
-
Jun 15, 2022 product/service
-
-
product/service
-
Notice Regarding Approval of Partial Amendments to Indications, Dosage and Administration of Imatinib Tablets 100mg “KMP” for KYOSOMIRAI PHARMA(153 KB)
-
-
Jan 26, 2022 product/service
-
-
product/service
-
Notice Regarding Approval of Partial Amendments to Indications and Usage of Ezetimibe Tablets 10mg “KMP” for KYOSOMIRAI PHARMA(118 KB)
